Neurobiology of Aging
Volume 31, Issue 5 , Pages 732-740 , May 2010

A comparative study to screen dementia and APOE genotypes in an ageing East African population

  • Chien-Hsiun Chen

      Affiliations

    • Laboratory of Neurogeriatrics, Department of Neurology and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
    • Current address of Dr C-H Chen, National Genotyping Center, Institute of Biomedical Sciences, Academia Sinica IBMS, 2 Academia Rd. Nangang, Taipei City 115, Taiwan.
    • ,
  • Toshiki Mizuno

      Affiliations

    • Department of Neurology, Kyoto Prefectural University, Kyoto, Japan
    • ,
  • Robert Elston

      Affiliations

    • Laboratory of Neurogeriatrics, Department of Neurology and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
    • ,
  • Monica M. Kariuki

      Affiliations

    • Department of Psychiatry, Provincial General Hospital, Nyeri, Kenya
    • ,
  • Kathleen Hall

      Affiliations

    • Departments of Psychiatry and Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    • ,
  • Fred Unverzagt

      Affiliations

    • Departments of Psychiatry and Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    • ,
  • Hugh Hendrie

      Affiliations

    • Departments of Psychiatry and Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
    • ,
  • Samuel Gatere

      Affiliations

    • Avenue Hospital, First Avenue Parklands, Nairobi, Kenya
    • ,
  • Paul Kioy

      Affiliations

    • Department of Medical Physiology, University of Nairobi, Kenya
    • ,
  • Nilesh B. Patel

      Affiliations

    • Department of Medical Physiology, University of Nairobi, Kenya
    • ,
  • Robert P. Friedland

      Affiliations

    • Laboratory of Neurogeriatrics, Department of Neurology and Department of Epidemiology and Biostatistics, School of Medicine, Case Western Reserve University, Cleveland, OH, USA
    • ,
  • Raj N. Kalaria

      Affiliations

    • Institute for Ageing and Health, Newcastle General Hospital, Newcastle upon Tyne NE4 6BE, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 191 248 1352; fax: +44 191 248 1301.

Received 13 September 2007 ,Revised 22 June 2008 ,Accepted 27 June 2008.

References 

  1. Baiyewu O, Smith-Gamble V, Lane KA, Gureje O, Gao S, Ogunniyi A, et al. Prevalence estimates of depression in elderly community-dwelling African Americans in Indianapolis and Yoruba in Ibadan. Nigeria Int. Psychogeriatr. 2007;19:679–689
  2. Borenstein AR, Wu Y, Mortimer JA, Schellenberg GD, McCormick WC, Bowen JD, et al. Developmental and vascular risk factors for Alzheimer's disease. Neurobiol. Aging. 2005;26:325–334
  3. Bowirrat A, Friedland RP, Farrer L, Baldwin C, Korczyn A. Genetic and environmental risk factors for Alzheimer's disease in Israeli Arabs. J. Mol. Neurosci. 2002;19:239–245
  4. Brayne C. The EURODEM collaborative reanalysis of case-control studies of Alzheimer's disease: implications for public health. Int. J. Epidemiol. 1991;20:568–571
  5. Buschke H, Kuslansky G, Katz M, Stewart WF, Sliwinski MJ, Eckholdt HM, et al. Screening for dementia with the memory impairment screen. Neurology. 1999;52:231–238
  6. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele?. Ann. Hum. Genet. 1999;63:301–310
  7. Corbo RM, Scacchi R, Rickards O, Martinez-Labarga C, De Stefano GF. An investigation of human apolipoproteins B and E polymorphisms in two African populations from Ethiopia and Benin. Am. J. Hum. Biol. 1999;11:297–304
  8. Corbo RM, Prevost M, Raussens V, Gambina G, Moretto G, Scacchi R. Structural and phylogenetic approaches to assess the significance of human Apolipoprotein E variation. Mol. Genet. Metab. 2006;89:261–269
  9. Evans DA, Funkenstein HH, Albert MS, Scherr PA, Cook NR, Chown MJ, et al. Prevalence of Alzheimer's disease in a community population of older persons. Higher than previously reported. JAMA. 1989;262:2551–2556
  10. Farrag A, Farwiz HM, Khedr EH, Mahfouz RM, Omran SM. Prevalence of Alzheimer's disease and other dementing disorders: Assiut–Upper Egypt study. Dement. Geriatr. Cogn. Disord. 1998;9:323–328
  11. Farrer LA, Cupples LA, Haines JL, Hyman B, Kukull WA, Mayeux R, et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. JAMA. 1997;278:1349–1356
  12. Farrer LA, Friedland RP, Bowirrat A, Waraska K, Korczyn A, Baldwin CT. Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel. J. Mol. Neurosci. 2003;20:207–212
  13. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al. Global prevalence of dementia: a Delphi consensus study. Lancet. 2005;366:2112–2117
  14. Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, et al. Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch. Neurol. 2000;57:824–830
  15. Grant, W.B., 2001. Incidence of dementia and Alzheimer disease in Nigeria and the United States. JAMA 285, 2448 (author reply 2448–2449).
  16. Green RC, Cupples LA, Kurz A, Auerbach S, Go R, Sadovnick D, et al. Depression as a risk factor for Alzheimer disease: the MIRAGE Study. Arch. Neurol. 2003;60:753–759
  17. Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, et al. APOE epsilon4 is not associated with Alzheimer's disease in elderly Nigerians. Ann. Neurol. 2006;59:182–185
  18. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke. 2006;37:2220–2241
  19. Hall K, Hendrie H, Brittain H, Norton JA. The development of a dementia screening interview in two distinct languages. Int. J. Methods Psychiatr. Res. 1993;3:1–28
  20. Hall K, Ogunniyi A, Hendrie H, Osuntokun BO, Hui S, Musick B, et al. A cross-cultural community based study of dementias: methods and perfomance of the survey instrument Indianpolis, USA and Ibadan, Nigeria. Int. J. Methods Psychiatr. Res. 1996;6:129–142
  21. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC. Community screening interview for dementia (CSI ‘D’); performance in five disparate study sites. Int. J. Geriatr. Psychiatry. 2000;15:521–531
  22. Hall K, Murrell J, Ogunniyi A, Deeg M, Baiyewu O, Gao S, et al. Cholesterol, APOE genotype, and Alzheimer disease: an epidemiologic study of Nigerian Yoruba. Neurology. 2006;66:223–227
  23. Heckmann JM, Low WC, de Villiers C, Rutherfoord S, Vorster A, Rao H, et al. Novel presenilin 1 mutation with profound neurofibrillary pathology in an indigenous Southern African family with early-onset Alzheimer's disease. Brain. 2004;127:133–142
  24. Hendrie HC, Hall KS, Pillay N, Rodgers D, Prince C, Norton J, et al Alzheimer's disease is rare in Cree. Int. Psychogeriatr. 1993;5:5–14
  25. Hendrie HC, Osuntokun BO, Hall KS, Ogunniyi AO, Hui SL, Unverzagt FW, et al. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatry. 1995;152:1485–1492
  26. Hendrie HC, Ogunniyi A, Hall KS, Baiyewu O, Unverzagt FW, Gureje O, et al. Incidence of dementia and Alzheimer disease in 2 communities: Yoruba residing in Ibadan, Nigeria, and African Americans residing in Indianapolis, Indiana. JAMA. 2001;285:739–747
  27. Hendrie HC, Murrell J, Gao S, Unverzagt FW, Ogunniyi A, Hall KS. International studies in dementia with particular emphasis on populations of African origin. Alzheimer Dis. Assoc. Disord. 2006;20:S42–S46
  28. Jorm AF, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol. Med. 1989;19:1015–1022
  29. Kalaria RN. The role of cerebral ischemia in Alzheimer's disease. Neurobiol. Aging. 2000;21:321–330
  30. Kalaria RN. Dementia comes of age in the developing world. Lancet. 2003;361:888–889
  31. Kalaria RN, Ballard C. Stroke and cognition. Curr. Atheroscler. Rep. 2001;3:334–339
  32. Kalaria RN, Ogeng’o JA, Patel NB, Sayi JG, Kitinya JN, Chande HM, et al. Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Brain Res. Bull. 1997;44:573–577
  33. Maj M, Janssen R, Satz P, Zaudig M, Starace F, Boor D, et al The World Health Organization's cross-cultural study on neuropsychiatric aspects of infection with the human immunodeficiency virus 1 (HIV-1). Preparation and pilot phase. Br. J. Psychiatry. 1991;159:351–356
  34. Mak Z, Kim JM, Stewart R. Leg length, cognitive impairment and cognitive decline in an African-Caribbean population. Int. J. Geriatr. Psychiatry. 2006;21:266–272
  35. Morgan OS, Eldemire DA, Thesiger CH, Luseko J, Sahota A, Gao S, et al. APOE allele frequencies in demented and nondemented elderly Jamaicans. Ann. Neurol. 1998;43:545
  36. Muriuki G. A History of the Kikuyu 1500–1900. Nairobi, Kenya: Oxford University Press; 1974;
  37. Ogunniyi A, Hall KS, Gureje O, Baiyewu O, Gao S, Unverzagt FW, et al. Risk factors for incident Alzheimer's disease in African Americans and Yoruba. Metab. Brain Dis. 2006;21:235–240
  38. Osuntokun BO, Hendrie HC, Ogunniyi AO, Hall KS, Lekwauwa UG, Brittain HM, et al. Cross-cultural studies in Alzheimer's disease. Ethn. Dis. 1992;2:352–357
  39. Osuntokun BO, Sahota A, Ogunniyi AO, Gureje O, Baiyewu O, Adeyinka A, et al Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians. Ann. Neurol. 1995;38:463–465
  40. Pandav RS, Chandra V, Dodge HH, DeKosky ST, Ganguli M. Hemoglobin levels and Alzheimer disease: an epidemiologic study in India. Am. J. Geriatr. Psychiatry. 2004;12:523–526
  41. Premkumar DR, Cohen DL, Hedera P, Friedland RP, Kalaria RN. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am. J. Pathol. 1996;148:2083–2095
  42. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet. 2003;361:909–917
  43. Prince M, Graham N, Brodaty H, Rimmer E, Varghese M, Chiu H, et al. Alzheimer Disease International's 10/66 Dementia Research Group – one model for action research in developing countries. Int. J. Geriatr. Psychiatry. 2004;19:178–181
  44. Prince M, Ferri CP, Acosta D, Albanese E, Arizaga R, Dewey M, et al. The protocols for the 10/66 Dementia Research Group population-based research programme. BMC Public Health. 2007;7:165
  45. Richards SS, Emsley CL, Roberts J, Murray MD, Hall K, Gao S, et al. The association between vascular risk factor-mediating medications and cognition and dementia diagnosis in a community-based sample of African-Americans. J. Am. Geriatr Soc. 2000;48:1035–1041
  46. Romas SN, Santana V, Williamson J, Ciappa A, Lee JH, Rondon HZ, et al. Familial Alzheimer disease among Caribbean Hispanics: a reexamination of its association with APOE. Arch. Neurol. 2002;59:87–91
  47. Sayi JG, Patel NB, Premkumar DR, Adem A, Winblad B, Matuja WB, et al. Apolipoprotein E polymorphism in elderly east Africans. East Afr. Med. J. 1997;74:668–670
  48. Scacchi R, De Bernardini L, Mantuano E, Donini LM, Vilardo T, Corbo RM. Apolipoprotein E (APOE) allele frequencies in late-onset sporadic Alzheimer's disease (AD), mixed dementia and vascular dementia: lack of association of epsilon 4 allele with AD in Italian octogenarian patients. Neurosci. Lett. 1995;201:231–234
  49. Stewart R, Russ C, Richards M, Brayne C, Lovestone S, Mann A. Apolipoprotein E genotype, vascular risk and early cognitive impairment in an African Caribbean population. Dement. Geriatr. Cogn. Disord. 2001;12:251–256
  50. WHO, 1984. The use of epidemiology in the study of the elderly. Report of a WHO Scientific Group on the Epidemiology of Aging. WHO Techn. Rep. Ser. 707, 9.
  51. WHO, 2002. Active ageing: a policy framework, 2002 health report. World Health Organisation, Geneva.
  52. Wimo A, Jonsson L, Winblad B. An estimate of the worldwide prevalence and direct costs of dementia in 2003. Dement. Geriatr. Cogn Disord. 2006;21:175–181
  53. Yang M, Hendrie HC, Hall KS, Oluwole OS, Hodes ME, Sahota A. Improved procedure for eluting DNA from dried blood spots. Clin. Chem. 1996;42:1115–1116

PII: S0197-4580(08)00229-7

doi: 10.1016/j.neurobiolaging.2008.06.014

Neurobiology of Aging
Volume 31, Issue 5 , Pages 732-740 , May 2010

Article Tools

* Image Usage & Resolution